Bellegrove Medical Associates Ps Inc is categorized under Internal Medicine Doctors in Bellevue, WA and active since 1967.
Bellegrove Medical Associates Ps Inc was established in 1967, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact David C Bontecou at the company’s single location by writing to 1515 116th Avenue Ne # 307, Bellevue, Washington WA 98004 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Bellegrove Medical Associates Ps Inc |
Contact Person: | David C Bontecou |
Address: | 1515 116th Avenue Ne # 307, Bellevue, Washington 98004 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1967 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Bellegrove Medical Associates Ps Inc was started in 1967 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David C Bontecou for inquiries that concern Bellegrove Medical Associates Ps Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Bellegrove Medical Associates Ps Inc can be found at the coordinates as well as the street address 1515 116th Avenue Ne # 307 in Bellevue, Washington 98004.
For its online presence, you may visit Bellegrove Medical Associates Ps Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.